Experimental Ebola Vaccine Shows Promise In Human Trial
A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects.By Evan Thomas | November 27, 2014
Initial human trials of an experimental ebola vaccine show promise, according to researchers at the National Institutes of Health.
A recent study exposed 20 healthy adults to the prototype drug, which was supposed to trigger an immune system response to Ebola.
According to a report published in the New England Journal of Medicine Wednesday, each patient showed antibody response “in the range reported to be associated with vaccine-induced protective immunity…” In other words, it appears to have worked.